Why is Remedium Life falling/rising?

As of 03-Jul, Remedium Lifecare Ltd's stock price is currently at 1.08, reflecting an increase of 0.02 or 1.89%. The stock has shown a strong performance recently, gaining 28.57% over the last seven days and outperforming its sector by 1.95%. However, despite this recent uptick, the stock has experienced significant declines over longer periods, with a year-to-date drop of 69.78% and a staggering 92.07% decrease over the past year. The company has reported negative financial results, including a high Debt to EBITDA ratio of -1.00 times and consecutive losses over the last three quarters, which contribute to its poor long-term growth outlook.
In the broader market context, while Remedium Lifecare's stock has risen in the short term, the benchmark Sensex has shown a decline of 0.62% over the past week. This indicates that the stock's recent gains are notable against a backdrop of broader market weakness. However, the company's long-term performance remains concerning, as it has underperformed the BSE500 index over multiple time frames, including the last three years and one year. The combination of recent gains and ongoing financial struggles creates a complex picture for investors, highlighting both potential short-term recovery and significant long-term risks.